Answers are grounded in this paper and cite their sources.
We have previously observed that Sp1, a ubiquitous zinc finger transcription factor, is phosphorylated during terminal differentiation in the whole animal, and this results in decreased DNA binding activity (Leggett, R. W., Armstrong, S. A., Barry, D., and Mueller, C. R. (1995) J. Biol. Chem.270, 25879–25884). In this study, we demonstrate that casein kinase II (CKII) is able to phosphorylate the C terminus of Sp1 and results in a decrease in DNA binding activity. This suggests that CKII may be responsible for the observed regulation of Sp1. Mutation of a consensus CKII site at amino acid 579, within the second zinc finger, eliminates phosphorylation of this site and the CKII-mediated inhibition of Sp1 binding. Phosphopeptide analysis confirms the presence of a CKII site at Thr-579 as well as additional sites within the C terminus. No gross changes in CKII subunit levels were seen during de-differentiation associated with liver regeneration. The serine/threonine phosphatase PP1 was identified as the endogenous liver nuclear protein able to dephosphorylate Sp1 but again no gross changes in activity were observed in the regenerating liver. Okadaic acid treatment of K562 cells increases Sp1 phosphorylation and inhibits its DNA binding activity suggesting that steady state levels of Sp1 phosphorylation are established by a balance between kinase and phosphatase activities. We have previously observed that Sp1, a ubiquitous zinc finger transcription factor, is phosphorylated during terminal differentiation in the whole animal, and this results in decreased DNA binding activity (Leggett, R. W., Armstrong, S. A., Barry, D., and Mueller, C. R. (1995) J. Biol. Chem.270, 25879–25884). In this study, we demonstrate that casein kinase II (CKII) is able to phosphorylate the C terminus of Sp1 and results in a decrease in DNA binding activity. This suggests that CKII may be responsible for the observed regulation of Sp1. Mutation of a consensus CKII site at amino acid 579, within the second zinc finger, eliminates phosphorylation of this site and the CKII-mediated inhibition of Sp1 binding. Phosphopeptide analysis confirms the presence of a CKII site at Thr-579 as well as additional sites within the C terminus. No gross changes in CKII subunit levels were seen during de-differentiation associated with liver regeneration. The serine/threonine phosphatase PP1 was identified as the endogenous liver nuclear protein able to dephosphorylate Sp1 but again no gross changes in activity were observed in the regenerating liver. Okadaic acid treatment of K562 cells increases Sp1 phosphorylation and inhibits its DNA binding activity suggesting that steady state levels of Sp1 phosphorylation are established by a balance between kinase and phosphatase activities. Sp1 was originally characterized as a GC box binding protein (1Briggs M.R. Kadonaga J.T. Bell S.P. Tjian R. Science. 1986; 234: 46-52Google Scholar) recognizing the consensus sequence GGGCGG. Its DNA binding domain consists of three C2H2 zinc fingers (2Kadonaga J.T. Carner K.C. Masiarz F.R. Tjian R. Cell. 1987; 51: 1079-1090Google Scholar), and a series of four domains required for transcriptional activity of Sp1 have been characterized (3Courey A.J. Tjian R. Cell. 1988; 55: 887-898Google Scholar). Two of these domains, A and B, correspond to glutamine-rich regions (4Buckler A.J. Chang D.D. Graw S.L. Brook J.D. Haber D.A. Sharp P. Housman D.E. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 4005Google Scholar, 5Kadonaga J.T. Courey A.J. Ladika J. Tjian R. Science. 1988; 242: 1566-1570Google Scholar, 6Courey A.J. Holtzman D.A. Jackson S.P. Tjian R. Cell. 1989; 59: 827-836Google Scholar) that interact with the transcriptional machinery by binding to TAFII110 (7Hoey T. Weinzierl R.O. Gill G. Chen J.-L. Dynlacht B.D. Tjian R. Cell. 1993; 72: 247-260Google Scholar) and are needed for transcriptional synergy to occur (8Pascal E. Tjian R. Genes Dev. 1991; 5: 1646-1656Google Scholar). Domain C contains a region of high charge and functions only weakly as an independent transactivation domain (4Buckler A.J. Chang D.D. Graw S.L. Brook J.D. Haber D.A. Sharp P. Housman D.E. Proc. Natl. Acad. Sci. U. S. A. 1991; 88: 4005Google Scholar). Domain D is required for synergistic activation in conjunction with the A and B domains and may be involved in the formation of higher order homomeric complexes (8Pascal E. Tjian R. Genes Dev. 1991; 5: 1646-1656Google Scholar). The zinc fingers and domain D may also be involved in the interaction of Sp1 with other proteins as they are required for binding to proteins such as YY1 (9Lee J.S. Galvin K.M. Shi Y. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 6145-6149Google Scholar), GATA-1 (10Merika M. Orkin S.H. Mol. Cell. Biol. 1995; 15: 2437-2447Google Scholar), and adenovirus E1A (11Liu F. Green M.R. Nature. 1994; 368: 520-525Google Scholar). Sp1 is a member of a small multi-gene family, with Sp2 and Sp3 being ubiquitously expressed (12Kingsley C. Winoto A. Mol. Cell. Biol. 1992; 12: 4251-4261Google Scholar,13Hagen G. Muller S. Beato M. Suske G. Nucleic Acids Res. 1992; 20: 5519-5525Google Scholar), whereas the expression of Sp4 may be limited to the brain (13Hagen G. Muller S. Beato M. Suske G. Nucleic Acids Res. 1992; 20: 5519-5525Google Scholar). Sp3 recognizes the same DNA sequences as Sp1 and may act as a repressor of Sp1-mediated activation (14Hagen G. Muller S. Beato M. Suske G. EMBO J. 1994; 13: 3843-3851Google Scholar). Sp1 has traditionally been considered to be a constitutive transcription factor and has been implicated in the regulation of a wide variety of housekeeping genes and genes involved in growth regulation (15Kadonaga J.T. Jones K.A. Tjian R. Trends Biochem. Sci. 1986; 11: 20-23Google Scholar). It is becoming increasingly clear that Sp1 binding and transactivation is regulated by a variety of stimuli. The retinoblastoma gene product appears to be able to modulate Sp1-mediated transactivation (16Kim S.J. Onwuta U.S. Lee Y.I. Li R. Botchan M.R. Robbins P.D. Mol. Cell. Biol. 1992; 12: 2455-2463Google Scholar, 17Udvadia A.J. Rogers K.T. Higgins P.D.R. Murata Y. Martin K.H. Humphrey P.A. Horowitz J.M. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3265-3269Google Scholar, 18Udvadia A.J. Templeton D.J. Horowitz J.M. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 3953-3957Google Scholar) possibly through the release of Sp1 from a negative regulator of transactivation (19Murata Y. Kim H.G. Rogers K.T. Udvadia A.J. Horowitz J.M. J. Biol. Chem. 1994; 269: 20674-20681Google Scholar). A variety of growth factors may regulate Sp1 activity as this transcription factor has been shown to mediate the epidermal growth factor stimulation of the gastrin promoter (20Merchant J.L. Shiotani A. Mortensen E.R. Shumaker D.K. Abraczinskas D.R. J. Biol. Chem. 1995; 270: 6314-6319Google Scholar), the insulin-like growth factor I regulation of the elastin gene (21Jensen D.E. Rich C.B. Terpstra A.J. Farmer S.R. Foster J.A. J. Biol. Chem. 1995; 270: 6555-6563Google Scholar), and the transforming growth factor-β-mediated activation of both the α2(I) collagen gene (22Inagaki Y. Truter S. Tanaka S. Di Liberto M. Ramirez F. J. Biol. Chem. 1995; 270: 3353-3358Google Scholar) and p15INK4B(23Li J.-M. Nichols M.A. Chandrasekharan S. Xiong Y. Wang X.-F. J. Biol. Chem. 1995; 270: 26750-26753Google Scholar). Transactivation of the insulin receptor gene by E1a is thought to be mediated by Sp1 (24Kim H.S. Lee J.K. Tsai S.Y. Mol. Endocrinol. 1995; 9: 178-186Google Scholar), and increased Sp1 activity may be involved in tumor progression of a carcinoma cell line (25Gunther M. Frebourg T. Laithier M. Fossar N. Bouziane-Ouartini M. Lavialle C. Brison O. Mol. Cell. Biol. 1995; 15: 2490-2499Google Scholar). Expression of the p21CIP1/WAF1 cyclin-dependent kinase inhibitor in response to phorbol ester and okadaic acid treatments is also mediated through Sp1 sites (26Biggs J.R. Kudlow J.E. Kraft A.S. J. Biol. Chem. 1996; 271: 901-906Google Scholar). These findings suggest that modulation of Sp1 activity plays a critical role in the regulation of cellular growth and differentiation. The Sp1 protein is subject to two different forms of post-translational modification. It is extensively glycosylated with O-linked sugars, which appear to play some role in transactivation (27Jackson S.P. Tjian R. Cell. 1988; 55: 125-133Google Scholar). It is also phosphorylated by a DNA-dependent protein kinase (28Jackson S.P. MacDonald J.J. Lees-Miller S.P. Tjian R. Cell. 1990; 63: 155-165Google Scholar), but this phosphorylation has not been shown to alter the activity of Sp1. Sp1 also becomes phosphorylated during the process of terminal differentiation (29Leggett R.W. Armstrong S.A. Barry D. Mueller C.R. J. Biol. Chem. 1995; 270: 25879-25884Google Scholar). This modification results in the down-regulation of the DNA binding activity of Sp1 in rat liver nuclear extracts as well as in extracts from other organs. In this study, we demonstrate that the serine/threonine kinase, casein kinase II (CKII), 1The abbreviations used are: CKII, casein kinase II; DTT, dithiothreitol; PAGE, polyacrylamide gel electrophoresis; aa, amino acid(s). 1The abbreviations used are: CKII, casein kinase II; DTT, dithiothreitol; PAGE, polyacrylamide gel electrophoresis; aa, amino acid(s). is able to phosphorylate the C terminus of Sp1 and results in decreased Sp1 DNA binding. This suggests that CKII may be responsible for the observed phosphorylation of Sp1 during terminal differentiation in vivo. Increased phosphorylation of Sp1 in response to okadaic acid treatment suggests that phosphatases may also be involved in the regulation of Sp1 phosphorylation levels. Nuclear extracts were prepared at a concentration of 5–10 μg/μl, according to Gorskiet al. (30Gorski K. Carneiro M. Schibler U. Cell. 1986; 47: 767-776Google Scholar), with the modifications described in Maireet al. (31Maire P. Wuarin J. Schibler U. Science. 1989; 244: 343-346Google Scholar). The liver regeneration extracts were prepared by treating adult male rats with CCl4 and preparing extracts on day 2 as described in Mueller et al. (32Mueller C.R. Maire P. Schibler U. Cell. 1990; 61: 279-291Google Scholar). Phosphorylation of full-length Sp1 produced using a vaccinia virus vector (Promega) or Sp1-maltose fusion proteins (see below) was carried out in a 15- or 20-μl reaction volume of 25 mm HEPES, pH 7.5, 34 mm KCl, 50 mmMgCl2 at 30 °C for 45 min in the presence of 1 μl of partially purified CKII, 5 μCi of [γ-32P]ATP, and ±15 μg of bovine serum albumin. Some reactions contained 100 ng of the indicated, unlabeled oligonucleotides shown below. cSp1:DBP site I:DBP site The were on an The gel was or and and The Sp1 fusion amino was using CKII as described The was to rat liver nuclear extracts in the presence or of phosphatase for the of were on a The gel was and were as described in and Schibler S. Schibler U. Cell. 1989; Scholar) that the binding reactions for min on the were on a polyacrylamide In the the was with the for 30 min on by the binding reaction with the being on a The is a purified of the Sp1 protein and was from The shown was used as the in by gel was and the Sp1 protein was using the and a The complexes were using the according to The and the CKII are and were a from These were using a phosphatase A of Sp1 was by reaction using DNA and Sp1 by R. as the and the Sp1 and Sp1 which and A at was with Sp1 and used to the and Sp1 and used to the of the Sp1 This also amino of Sp1, but contains a to at within the second zinc were used to the Sp1 at the and The were Sp1 in was using and sites a binding protein fusion expression vector were and protein were according to with the from a were and in of protein pH 50 mm 1 mm 100 and mm DTT, 1 and 1 mm 1 was and the was on for 30 min and 1 of 5 was with a of min on and the was at in a for 30 min at Two of the was to a and was with 2 of mm HEPES, pH mm mm KCl, 1 mm 100 The fusion protein was with 2 1 of with mm and 100 the protein were and the protein was by the of to 5 and on for 1 were mm and 100 and with 1 mm and 100 to the protein in the presence of The Sp1 and Thr-579 proteins used in 2 were purified on a Sp1-maltose binding protein fusion proteins that been phosphorylated as described were on a gel and protein The was in for 1 min and 2 min in 1 of and the region the protein was were in in 100 mm acid at °C for 30 min and with 5 1 of by 50 mm The were in μl of 50 pH μg of for at μg of was and the was for a at The was with μl of for 5 min at and the and The was in μl of and two The was in 50 μl of acid μl of acid 100 μl of min at and on for 1 The was 1 of was The was in μl of pH on a and in the using the pH for 1 at on the The were in the second by with the The were and K562 a cell were in in at in with bovine serum and 50 of Sp1 phosphorylation was by the with okadaic acid at a concentration of 100 Nuclear extracts were prepared according to et E. P. Muller Nucleic Acids Res. 1989; Scholar), treatment or 2 the of okadaic We have previously observed that Sp1 is phosphorylated in nuclear extracts prepared from rat liver as well as from a variety of other (29Leggett R.W. Armstrong S.A. Barry D. Mueller C.R. J. Biol. Chem. 1995; 270: 25879-25884Google Scholar). This phosphorylation results in an decrease in the of Sp1 for its The site or sites phosphorylated in Sp1 as well as the kinase responsible have not been of the sequence of Sp1 three phosphorylation sites for CKII, of which is within the second zinc finger of the DNA binding domain of Sp1. The down-regulation of activity by CKII during growth A. J. T. T. N. U. T. D. M. Cell. 1992; Scholar) a of this kinase in Sp1 phosphorylation during terminal differentiation. the role of CKII in Sp1 the of CKII phosphorylation on Sp1 DNA binding activity was purified Sp1 prepared from a vaccinia virus vector was used in a with a consensus Sp1 site as the CKII Sp1 Sp1 with CKII and or Sp1 with CKII but no were both CKII and were was the binding of Sp1 in kinase using was also carried out with purified CKII and Sp1 to Sp1 is a for of Sp1 was observed only in the presence of both proteins 1 to the presence of the CKII site within the second zinc finger of Sp1, that binding of a DNA to Sp1 with oligonucleotides to high Sp1 sites from the from site II of the gene promoter and from the retinoblastoma which has a for Sp1 but which is (29Leggett R.W. Armstrong S.A. Barry D. Mueller C.R. J. Biol. Chem. 1995; 270: 25879-25884Google Scholar), were to the kinase the of The binding of these oligonucleotides in a decrease in the phosphorylation of Sp1 by CKII 2 The of binding sites no on CKII phosphorylation I and Sp1 for CKII-mediated a binding protein fusion was that the Sp1 zinc finger domain and the D from amino to This region contains only consensus CKII A of this was also that changes the in the CKII consensus site from a to an which the These proteins were purified on a being used in the binding and kinase proteins to a consensus Sp1 site with 2 Phosphorylation with purified CKII the binding of the and this was on the presence of This the amino of Sp1 as being for being by In binding of the protein the at Thr-579 was not by treatment with CKII and Phosphorylation of Thr-579 is required for CKII-mediated inhibition of Sp1 DNA binding activity. The of this on Sp1 phosphorylation was using an in kinase with the same two proteins are phosphorylated to a with the Thr-579 being 2 This that Thr-579 is not the or the CKII phosphorylation site within the region of Sp1 from to The binding protein was not phosphorylated by CKII not Phosphorylation of the protein is also by the in of the protein in the reaction CKII treatment these results that Thr-579 is for CKII-mediated inhibition of Sp1 DNA binding activity not the phosphorylation site in this the of Sp1 phosphorylation by binding of a suggests that these other CKII sites are in some also DNA binding. analysis of the and Thr-579 fusion proteins was carried out to the presence of an CKII phosphorylation site at are with the full-length protein with the in both of the sites in Sp1 that two from The presence of both and in 2 not that this is the as the to not The of this be with its in the 1 appears to a product of of the Thr-579 that both of the and are the that contains and its that this site is phosphorylated by which also is a product as is a to the in this that at or the other by is These that as well as a of and possibly within the D are phosphorylated by In the regenerating rat liver Sp1 is phosphorylated with the liver (29Leggett R.W. Armstrong S.A. Barry D. Mueller C.R. J. Biol. Chem. 1995; 270: 25879-25884Google Scholar). The of CKII to alter Sp1 binding to changes in CKII subunit levels in rat liver nuclear extracts are responsible for the in Sp1 analysis of the and CKII in nuclear extracts from and regenerating liver that the levels of three proteins were the same in both This that gross CKII subunit levels were not subject to regulation but not out in activity to other The that of Sp1 be regulated to the of endogenous phosphatases that dephosphorylate Sp1. The Sp1 fusion protein was phosphorylated with CKII and and with rat liver nuclear These extracts were able to dephosphorylate Sp1 the of a 5 of okadaic acid were which serine/threonine phosphatases at 5 100 of okadaic acid was and this inhibition was a of phosphatase This that is PP1 that is able to dephosphorylate Sp1. This phosphatase has been to be regulated some M. A. P. J. J. T. M. S. M. Cell. 1992; Scholar, P. Biochem. 1989; Scholar). the phosphatase activity in and regenerating rat liver nuclear extracts was using a no in phosphatase levels was observed 5 of casein kinase Sp1. the Sp1 fusion protein was phosphorylated using purified CKII and and with μg of regenerating rat liver nuclear in the presence or of phosphatase The phosphatase inhibitor of a concentration of 1 of and Okadaic acid was at the The reactions were on a gel and the of the Sp1 fusion reactions were carried out as described in A that nuclear extracts from both and regenerating liver were The reactions were carried out for the at which they were by the of The reactions were on a gel and The the of the Sp1 fusion In are limited in that they may for regulation of a Sp1 phosphorylation is a process both phosphorylation and the of okadaic acid treatment on Sp1 phosphorylation in was K562 cells were with 100 okadaic acid for 2 at which nuclear extracts were with the consensus Sp1 using and okadaic that Sp1 DNA binding activity is by okadaic acid treatment of an Sp1 results in a of of the in the that this factor is Sp1. The DNA binding activity Sp3 which is subject to regulation as Sp1. in A of these is shown in B to the of in DNA binding activity. of these extracts using phosphatase Sp1 DNA binding activity in the okadaic and the protein was again using a The extracts were also using an binding site binding activity in and that protein is in the analysis of Sp1 protein in these extracts was also carried out Sp1 was in the but the were not No in of the protein treatment with okadaic or were This that the of phosphorylation of these proteins is not high to The phosphatase treatment of these extracts increases the DNA binding activity of Sp1 in the suggesting that a of Sp1 in the phosphorylated in these These not which kinase is responsible for Sp1 phosphorylation in vivo. by the endogenous okadaic acid treatment results in the phosphorylation of the of Sp1, that Sp1 phosphorylation is an process in the that down-regulation of Sp1 DNA binding activity by phosphorylation during terminal differentiation (29Leggett R.W. Armstrong S.A. Barry D. Mueller C.R. J. Biol. Chem. 1995; 270: 25879-25884Google Scholar) to which kinase was involved in this The presence of consensus CKII phosphorylation sites in Sp1, as well as CKII phosphorylation to growth A. J. T. T. N. U. T. D. M. Cell. 1992; Scholar), a role for this kinase in this In the of of these CKII sites within the second zinc finger of Sp1 was of a by which phosphorylation with binding of Sp1 to The that CKII is able to phosphorylate full-length Sp1 produced from a vaccinia virus vector and that this phosphorylation with Sp1 DNA binding activity that CKII is able to regulate Sp1 activity. The of CKII to both phosphorylate and the binding of a fusion protein the amino of Sp1 the CKII phosphorylation site to this In the of an Sp1 site to the of the CKII-mediated phosphorylation of both the full-length and proteins suggests that this region contains or of the of the in the consensus CKII site not CKII phosphorylation of Sp1, suggesting that other CKII sites in the C terminus of Sp1. This is with acid analysis which that the of phosphorylation on and not not analysis the and Thr-579 proteins that is the eliminates the of CKII to the binding of Sp1 to its of the of Sp1 R.W. Proc. Natl. Acad. Sci. U. S. A. 1992; Scholar) from that of Science. 1991; Scholar) that Thr-579 in a the of the DNA Phosphorylation of this a and that the of the zinc finger of Sp1 to binding activity is thought to be of the other two Mol. Cell. Biol. 1991; 11: Scholar), this the observed decrease in binding The Thr-579 is the only consensus CKII site in the phosphorylation of sites has been observed in 1990; Scholar). The of the CKII phosphorylation is on and appears to be in the D within a from to This region contains 5 and 5 The binding of a to Sp1 CKII-mediated to the of DNA binding be to the of CKII to this of D domain phosphorylation by DNA binding suggests that some may both the zinc finger domain and the D the CKII sites in a that of these sites in a region of the kinase is subject to by the presence of or DNA binding results in a which the CKII sites in the D We have previously observed changes in the phosphorylation state of Sp1 during liver and regeneration (29Leggett R.W. Armstrong S.A. Barry D. Mueller C.R. J. Biol. Chem. 1995; 270: 25879-25884Google Scholar). CKII has been associated with the of growth through its to phosphorylate and the A. J. T. T. N. U. T. D. M. Cell. 1992; Scholar). In of CKII as a of or in a CKII results in P. Science. 1995; Scholar). of these suggest a role for CKII in growth The of Sp1 in retinoblastoma (16Kim S.J. Onwuta U.S. Lee Y.I. Li R. Botchan M.R. Robbins P.D. Mol. Cell. Biol. 1992; 12: 2455-2463Google Scholar, A.J. Rogers K.T. Higgins P.D. Murata Y. Martin K.H. Humphrey P.A. Horowitz J.M. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3265-3269Google Scholar, T. K. K. S. R. Mol. Cell. Biol. 1994; Scholar) and the of Sp1 to regulate critical factors in growth regulation such as p21CIP1/WAF1 (26Biggs J.R. Kudlow J.E. Kraft A.S. J. Biol. Chem. 1996; 271: 901-906Google Scholar) may that CKII-mediated regulation of Sp1 is a critical in from the cell as the of terminal differentiation. of gross CKII subunit levels and phosphatase activity in and regenerating rat liver nuclear extracts has not changes in activity. in K562 cells that Sp1 phosphorylation is a the phosphorylation and of Sp1 to steady state levels. We have not been able to that CKII is responsible for PP1 has been to modulate Sp1 activity in response to the activation of the gene S. S. Kim J. Biol. Chem. 1996; 271: Scholar). In PP1 activity may be by phosphorylation E. F. Biochem. Res. 1996; Scholar) or through its with proteins such as A. S. M. S. F. M. J. Biol. Chem. 1995; 270: Scholar) and A. S. M. S. F. M. J. Biol. Chem. 1995; 270: Scholar). PP1 activity in the as well as is in rat cells M. Y. N. Y. R. 1995; Scholar). It has been that the of CKII is during P.A. J.M. J. Cell. Biochem. 1995; Scholar) and regeneration F. R. E. O. Biochem. Res. 1996; Scholar). It may be that interaction between CKII or PP1 and Sp1 is by or that other factors are able to or the by which Sp1 phosphorylation levels are appear to be a critical in the regulation of cellular We for and for purified casein kinase II as well as for the casein kinase II We also the of from
No takes yet. Share an insight, caveat, or question.
Armstrong et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: